U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, …
Over the last 12 months, insiders at U.S. Physical Therapy, Inc. have bought $172,180 and sold $3.51M worth of U.S. Physical Therapy, Inc. stock.
On average, over the past 5 years, insiders at U.S. Physical Therapy, Inc. have bought $317,647 and sold $4.32M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Gilmartin Kathleen A (director) — $172,180.
The last purchase of 2,000 shares for transaction amount of $172,180 was made by Gilmartin Kathleen A (director) on 2024‑09‑03.
2024-11-12 | Sale | director | 2,000 0.0134% | $92.95 | $185,900 | +0.94% | ||
2024-11-08 | Sale | Co-Chief Operations Officer | 2,000 0.0134% | $95.84 | $191,680 | -2.10% | ||
2024-11-08 | Sale | COO | 1,724 0.0116% | $96.29 | $166,004 | -2.10% | ||
2024-11-08 | Sale | director | 2,000 0.0134% | $95.78 | $191,560 | -2.10% | ||
2024-11-08 | Sale | director | 1,172 0.0079% | $96.72 | $113,356 | -2.10% | ||
2024-09-03 | director | 2,000 0.0133% | $86.09 | $172,180 | -2.51% | |||
2024-08-21 | Sale | COO | 1,724 0.0114% | $82.50 | $142,230 | +0.99% | ||
2024-05-30 | Sale | Chairman of the Board and CEO | 2,900 0.0192% | $100.26 | $290,754 | -13.52% | ||
2024-05-29 | Sale | Chairman of the Board and CEO | 1,000 0.0067% | $100.13 | $100,130 | -13.02% | ||
2024-05-28 | Sale | Chairman of the Board and CEO | 1,100 0.0073% | $102.13 | $112,343 | -14.41% | ||
2024-05-15 | Sale | director | 2,500 0.0165% | $107.57 | $268,925 | -16.42% | ||
2024-05-10 | Sale | Co-Chief Operations Officer | 2,500 0.0163% | $104.22 | $260,550 | -15.12% | ||
2024-05-10 | Sale | COO | 1,724 0.0113% | $105.46 | $181,813 | -15.12% | ||
2024-03-13 | Sale | Chief Financial Officer | 1,800 0.0119% | $107.28 | $193,103 | -10.88% | ||
2024-03-13 | Sale | EVP Gen'l Counsel & Secretary | 2,000 0.0132% | $106.55 | $213,100 | -10.88% | ||
2024-03-13 | Sale | director | 400 0.0026% | $107.00 | $42,800 | -10.88% | ||
2024-03-13 | Sale | director | 500 0.0033% | $107.89 | $53,945 | -10.88% | ||
2024-03-04 | Sale | Co-Chief Operations Officer | 1,500 0.0099% | $104.96 | $157,440 | -8.42% | ||
2024-03-04 | Sale | COO | 2,629 0.0173% | $104.39 | $274,441 | -8.42% | ||
2024-03-04 | Sale | director | 2,500 0.0164% | $104.26 | $260,650 | -8.42% |
READING CHRISTOPHER J | Chairman of the Board and CEO | 95838 0.6349% | $98.04 | 2 | 36 | +45% |
HENDRICKSON CAREY P | Chief Financial Officer | 21186 0.1404% | $98.04 | 1 | 3 | <0.0001% |
Gilmartin Kathleen A | director | 18904 0.1252% | $98.04 | 8 | 0 | +0.51% |
Trier Clayton | director | 6424 0.0426% | $98.04 | 1 | 23 | +34.23% |
KOSBERG J LIVINGSTON | director | 155000 1.0268% | $98.04 | 1 | 3 | +12.2% |
BlackRock | $259.85M | 15.28 | 2.3M | -0.69% | -$1.8M | 0.01 | |
KAYNE ANDERSON INVESTMENT MANAGEMENT LLC | $149.43M | 8.79 | 1.32M | -3.06% | -$4.72M | 0.35 | |
Morgan Stanley | $128.67M | 7.57 | 1.14M | +2.08% | +$2.62M | 0.01 | |
The Vanguard Group | $121.06M | 7.12 | 1.07M | +0.96% | +$1.15M | <0.01 | |
T Rowe Price Investment Management Inc | $87.25M | 5.13 | 773,008 | +1.54% | +$1.33M | 0.05 |